Engflag

Medichol

Quick links to important sections

Medichol

Medichol_EN

Method of action: Bacteriostatic, Ophthalmologicals

Treatment option: Abscess, Brain Abscess, Brucellosis, Influenza, Dysentery, Skin Conditions, Infection, Carbuncle, Fever, Peritonitis

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Medichol

Quick Facts

Property Description
Active ingredient Chloramphenicol (INN)
Forms Oral capsules, injectable solution, eye drops, ear drops, ointment
Pharmacological class Broad-spectrum antibiotic, Amphenicol-class Antibacterial
Common use Control of severe bacterial infections and localized surface infections
Origin Semi-synthetic (derived from Streptomyces venezuelae)

What Type of Medicine is Medichol? (Identity and Class)

Medichol is a commercial brand of medicine containing the active ingredient Chloramphenicol, and it is classified as a broad-spectrum antibiotic and an Antimicrobial Agent belonging to the specialized Amphenicol-class Antibacterials. The primary purpose of preparations containing Chloramphenicol is to control and relieve bacterial infections by targeting a wide variety of microbial pathogens. This substance is considered a powerful, high-potency agent, typically categorized as prescription-only (Rx) due to its profile, and is often reserved for specific or severe bacterial threats where common, first-line antibiotics are unsuitable or ineffective. Chloramphenicol remains critical for managing serious infections in specific clinical contexts.

Composition and Physical Forms Available

The core of Medichol is the Chloramphenicol molecule, which, despite having been originally isolated from the bacterium Streptomyces venezuelae, is now entirely synthetically manufactured for pharmaceutical use. To facilitate its delivery, Medichol is available in diverse pharmaceutical preparations, including oral capsules, a sterile injectable solution for systemic use, and localized topical forms such as eye drops and ointment. The active substance often exists as an ester, like Chloramphenicol sodium succinate for injection or Chloramphenicol palmitate for oral liquid, a formulation difference necessary for proper absorption. The chemical structure of Chloramphenicol allows for effective tissue penetration due to its lipid solubility, aiding its utility in these various forms.

How Medichol Provides General Antimicrobial Benefit

Medichol provides an antimicrobial benefit through its principle mechanism of acting primarily as a bacteriostatic agent. This means the medicine limits the growth and ability of the bacteria to multiply by specifically halting their protein production. This highly effective action against proliferating bacterial threats positions Chloramphenicol as an essential reserve antibiotic that helps the body effectively contain and overcome wide-ranging microbial challenges when its use is clinically necessary. This bacteriostatic principle applies across diverse pathogens.

Regulatory References

  1. WHO Essential Medicines List (EML)

What side effects are possible with Medichol?

Possible Side Effects and Safety Information

The safety profile of Medichol (Chloramphenicol) is defined by officially documented hematological, neurological, and population-specific toxicities, as classified in regulatory labeling. The most serious concern is the risk of aplastic anemia, which is considered an idiosyncratic, irreversible, and non-dose-related form of bone marrow failure. This rare, but potentially fatal, adverse reaction can have a delayed onset, occurring weeks or months after cessation of therapy.

A separate, reversible bone marrow depression is also documented as a common, dose-related effect, characterized by changes such as a reduction in blood cell precursors. Other system-organ classes affected include Nervous System Disorders like optic neuritis and peripheral neuritis, with vision loss being associated with long-term use. Gastrointestinal issues such as nausea, vomiting, and diarrhea are also listed.

Population-Specific Safety Constraints

A unique and often fatal reaction, known as "Gray Syndrome," is explicitly documented in premature and newborn infants. This toxicity is linked to their reduced capacity to metabolize and excrete the medicine. Furthermore, regulatory documents confirm that the serious risk of bone marrow suppression, including aplastic anemia, has been reported following topical use (eye drops/ointment), indicating that systemic absorption occurs even with localized administration. The label advises against co-administration with other substances known to depress bone marrow function.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage of Medichol (Chloramphenicol) is defined in regulatory labeling by the potential for serious, life-threatening toxic effects, primarily linked to high serum concentrations, which are frequently considered toxic when exceeding 25 mu g/ mL.

Documented Manifestations and Severe Outcomes

The official overdose presentation may include symptoms such as nausea, vomiting, and diarrhea. The most serious risks are documented as fatal blood dyscrasias, specifically aplastic anemia and dose-related, reversible bone marrow depression, affecting the hematological system.

A unique, often fatal, toxic reaction documented in newborns and premature infants is the Gray Syndrome. This severe outcome is officially characterized by abdominal distention, progressive pallid cyanosis, vasomotor collapse, and irregular respiration. Patients with impaired liver or kidney function are also noted to be at increased risk of toxicity due to compromised clearance.

When to Seek Immediate Medical Help

Immediate medical attention is required upon observing any sign of severe toxicity or the rapid onset of symptoms resembling the Gray Syndrome. Management is officially described as symptomatic and supportive. Procedural guidance mentions that charcoal hemoperfusion may be considered for serious overdosage, but no specific antidote is known to be available in regulatory labeling. The need for urgent help is based entirely on the severity classifications of the documented systemic risks.

Therapeutic Uses of Medichol

What Medichol Treats: Main Uses and Benefits

Medichol (Chloramphenicol) is commonly used across distinct clinical settings to manage bacterial infections, focusing on helping to manage the infection to provide supportive relief and contributing to patient comfort. Its clinical application is highly specific.

The medicine is relevant for easing symptoms associated with serious systemic conditions such as bacterial meningitis and typhoid fever, in situations where the medicine is considered relevant. It is used in addressing symptom clusters related to systemic imbalance and high fever.

It is also applied in managing localized acute episodes, including bacterial conjunctivitis (with redness and purulent discharge) and external ear infections (otitis externa).

In these scenarios, Medichol is considered a relevant therapeutic option for managing persistent infections where standard treatments are unsuitable or resistance is a concern. This may assist in ultimately reducing the overall symptomatic burden and supports patients during episodes of heightened discomfort.

Quick Fact: Relief for Acute Discomfort
Medichol assists with maintaining functional stability and contributes to improved comfort during periods where localized symptoms like discharge and pain interfere with routine activities.

Regulatory References

  1. NIH StatPearls overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Medichol? — Official Regulatory Information

The eligibility profile for Medichol (Chloramphenicol) is strictly defined by regulatory authorities and mandates exclusion for certain populations due to risk.

Eligibility Scope

Category Official Regulatory Status
Populations for whom use is allowed Adults and older children, generally for short-term use in severe infections. Older adults may require therapeutic monitoring.
Populations for whom use is contraindicated Individuals with a history of hypersensitivity or toxic reaction to the drug. Patients with a known personal or family history of blood dyscrasias, including aplastic anemia, or a history of myelosuppression.
Age-related eligibility rules Use in neonates (premature and full-term) is highly restricted and requires extreme caution due to the risk of the fatal "Gray Syndrome."
Condition-specific eligibility rules Patients with impaired hepatic or renal function are restricted to conditional use and require careful monitoring and potential dose reduction.
Pregnancy and lactation eligibility status Systemic use is generally contraindicated during pregnancy and breastfeeding.

Eligibility Classifications

Official eligibility statements:

  • The drug is not recommended for the treatment of trivial infections (such as colds or influenza) or for use as a prophylactic agent.
  • Co-administration with other medications known to suppress bone marrow must be avoided.

Connection to the overall eligibility profile

Regulatory documents impose absolute contraindications based on hematological and allergic history, and they define conditional eligibility for those with metabolic limitations, such as neonates or patients with organ impairment. The official profile mandates that the medicine be reserved for specific, severe conditions, thereby excluding broad use across the general population.

What should I know about interactions with other medicines?

Medichol Interactions with other medicines and products

Medichol, like all prescription medicines, carries a potential for interaction with other drugs, specific food items, or certain medical conditions. Understanding these interactions is a critical component of safe use. Always inform your healthcare provider of all current medications, including over-the-counter products, vitamins, and herbal supplements.

Potential Drug Interactions

Interactions with other medicines may alter the effects of either Medichol or the co-administered drug. This may result in increased side effects or reduced effectiveness. While specific clinical data for all combinations are extensive and depend on the exact formulation, the following general categories are often noted to require careful monitoring or dosage adjustment:

  • Agents affecting the Central Nervous System (CNS): Products that cause sedation or depress the CNS may have enhanced effects when combined with Medichol, potentially leading to increased drowsiness or dizziness.
  • Medicines that impact specific metabolic pathways: Drugs that significantly inhibit or induce certain hepatic enzymes may affect the concentration of Medichol in the bloodstream, necessitating close supervision. This is a common mechanism for pharmacokinetic drug-drug interactions.

Food, Beverage, and Condition Interactions

  • Alcohol: Consumption of alcohol during Medichol therapy should be discussed with a doctor, as it can heighten the risk of certain side effects.
  • Pre-existing Medical Conditions: Dosage and suitability of Medichol may be dependent on the presence of certain chronic conditions. For instance, individuals with compromised renal or hepatic function may require dose adjustments due to altered drug clearance.

Patients should not begin or discontinue any medication without consulting a healthcare professional to ensure all combinations are assessed for clinical significance.

Mechanism of Action

The action of Medichol (Chloramphenicol) is defined by its ability to execute a targeted and selective inhibition of core metabolic machinery inside the bacterial cell, resulting in the physiological containment of the pathogen population.

Specific Molecular Targeting of Bacterial Translation

This domain covers the drug's interaction with its sole primary target: the 50S ribosomal subunit of susceptible bacteria. Medichol rapidly penetrates the bacterial cell membrane and reversibly binds to the 23S ribosomal RNA component, functioning as a precise inhibitor of the essential peptidyl transferase enzyme. This molecular blockade arrests the formation of new peptide bonds, which is the necessary step for the elongation of polypeptide chains.

The Cascade to Pathogen Proliferation Control

The cessation of protein synthesis immediately halts the production of all essential functional and structural proteins required for bacterial growth and cell division. This mechanism leads to a bacteriostatic effect, which prevents the proliferation and growth of the microbial population. The resulting physiological consequence is the containment of the microbial burden, which permits the host's natural clearance mechanisms to act on the non-replicating pathogens.

Mechanistic Constraints and Selectivity

Medichol demonstrates mechanistic selectivity by primarily engaging the bacterial 50S ribosome over the structurally distinct human 80S ribosome. However, the mechanism is functionally constrained by bacterial resistance, specifically the enzymatic inactivation of the drug by Chloramphenicol acetyltransferase (CAT), which chemically modifies the molecule and prevents it from binding to its ribosomal target.

Dosage and Administration Information

Official Administration Guidelines for Medichol (Oral Route)

Medichol, an oral preparation of cholecalciferol (Vitamin D3), must be taken exactly as prescribed by a healthcare provider or as directed on the product label. The official instructions for use are structured around two phases: a loading period to address deficiency and a subsequent maintenance phase.

Dosage and Frequency

Administration Scope Official Regulatory Statement
Route of Administration Oral
Loading Dose (Deficiency) A total of 300,000 International Units (IU) administered over 5 to 10 weeks. This may involve taking 30,000 IU or 60,000 IU once weekly (depending on the chosen regimen).
Maintenance Dose Following the loading period, a dose of 2,000 IU once daily is commonly used for continued maintenance.

Procedural and Special Conditions

  • Preparation: Medichol is available in various oral forms, including capsules, tablets, and liquid drops. If using a liquid solution, the prescribed dose should be measured using the dropper provided, or as directed, and may be administered directly into the mouth or mixed with food or liquid. Chewable wafers must be crushed or chewed, not swallowed whole.
  • Missed Dose: If a dose is missed, take it as soon as possible. However, if it is almost time for the next scheduled dose, skip the missed one and return to the regular schedule. Do not double the dose to compensate.
  • Monitoring and Adjustment: Administration is guided by an initial assessment of the patient's baseline serum 25( OH) D levels. Dosage adjustments, if necessary, should be individualized based on ongoing monitoring and typically should not be increased more often than every four weeks.

Note: It is critical to follow the specific instructions on the label or from your healthcare professional, as they are tailored to individual health status and product formulation.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Efficacy Studies

Research has explored the drug's role in the management of the disease. Studies examined the drug's role in assessing changes in various symptoms in adults.

  • Randomized Controlled Trials (RCTs): A randomized controlled trial (RCT) evaluated whether the active ingredient was associated with changes in symptom severity. The study focused on participants diagnosed with the condition.
  • Alternative Treatment Use: This study explored whether use of the active ingredient was associated with changes in the use of alternative treatments. The research was conducted over a period of six months.
  • Dosage Analysis: One study explored the relationship between different approved dosages and observed changes in outcomes. The study compared results across standard and maximum approved doses.

Observational Data

Studies have also evaluated the drug's use outside of controlled clinical trial settings, primarily focusing on long-term effects.

  • Chronic Pain Research: Research examined the effects of combination therapy with drug X on pain scores in patients with chronic pain. This observational work sought to describe outcomes for patients using the combination treatment.
  • Quality of Life: Preliminary data from an observational study suggested an association between long-term use and changes in quality of life metrics in the study population. These results are drawn from a small cohort followed for two years.

Tolerability Research

Research investigating the drug's tolerability has examined reported side effects in various populations.

  • Pediatric Use: Other research investigated the drug's use and reported side effects in pediatric populations. The researchers noted the types of adverse events that were reported in this group.
  • Adverse Event Review: A review examined the reported side effects and tolerability data of the drug. The analysis included data from multiple clinical trials and post-marketing surveillance reports.

Studies have explored the potential role of this treatment in managing the condition, with research continuing to evaluate its various aspects.

How should Medichol be stored and disposed of?

How to Store and Dispose of Medichol?

Medichol (Chloramphenicol) must be stored and handled according to specific rules mandated by regulatory bodies to maintain its effectiveness and ensure safety.

Official Storage Requirements

Item Requirement Summary
Temperature and Environment Store in a cool, dry, well-ventilated area, generally at room temperature (15–25 C). The product must be kept from freezing and stored away from excessive heat and light.
Container and Protection Keep the medicine in its tightly closed container to protect it from moisture. Specific formulations, like the ophthalmic solution, may require refrigeration before dispensing.
Stability and Safety The medicine must be stored out of the sight and reach of children. The ophthalmic solution must be discarded after 21 days of use or dispensing, even if some product remains.

Disposal Instructions

Disposal of unused or expired Medichol must follow environmental rules. Do not release the product into the environment, including drains, surface water, or ground water. All waste material should be disposed of in accordance with local requirements and often to an approved waste disposal plant.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagUSA

Equivalent of Medichol found in:

A-Z Index: